Skip to content
naulon
Not checkedNot checked for notices yet.

Sphingolipids in COPD

Raja Chandra Chakinala, Akshay Khatri, Kriti Gupta and 2 more

European Respiratory Review · 2019

doi:10.1183/16000617.0047-2019 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Sphingolipids are a distinct class of lipid molecules widely found in nature, principally as cell membrane constituents. After initial uncertainty about their function, sphingolipids have been increasingly recognised to be metabolically active entities involved in many biological processes, including the control of inflammation. Their role as mediators of inflammation may have significant implications for a range of lung diseases in which inflammation is a central element of pathogenesis. Chronic obstructive pulmonary disease (COPD), a highly prevalent and morbid condition predominantly affecting cigarette smokers, is a prime example of a respiratory illness with an inflammatory component. Understandably, sphingolipids have received growing attention for their increasingly demonstrated role in the pathophysiology of COPD. The present review aims to be among the first to focus exclusively on the connection between sphingolipids and lung inflammation in COPD, providing the reader with a clinically oriented synopsis of this intriguing association.

Abstract licence: CC BY-NC

References44

  1. 40.

39 more references, whose wording the paper’s licence keeps private.

All 44 references

Cited by papers we hold2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.